|
Originally published In Press as doi:10.1074/jbc.M501156200 on February 10, 2005
J. Biol. Chem., Vol. 280, Issue 14, 13512-13519, April 8, 2005
Inhibition of Host and Viral Translation during Vesicular Stomatitis Virus Infection
eIF2 IS RESPONSIBLE FOR THE INHIBITION OF VIRAL BUT NOT HOST TRANSLATION*
John H. Connor and
Douglas S. Lyles
From the
Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
In cells that allow replication of vesicular stomatitis virus (VSV), there are two phases of translation inhibition: an early block of host translation and a later inhibition of viral translation. We investigated the phosphorylation of the subunit of the eIF2 complex during these two phases of viral infection. In VSV-infected cells, the accumulation of phosphorylated (inactivated) eIF2 did not begin until well after host protein synthesis was inhibited, suggesting that it only plays a role in blocking viral translation later after infection. Consistent with this, cells expressing an unphosphorylatable eIF2 showed prolonged viral protein synthesis without an effect on host protein synthesis inhibition. Induction of eIF2 phosphorylation at early times of viral infection by treatment with thapsigargin showed that virus and host translation are similarly inhibited, demonstrating that viral and host messages are similarly sensitive to eIF2 phosphorylation. A recombinant virus that expresses a mutant matrix protein and is defective in the inhibition of host and virus protein synthesis showed an altered phosphorylation of eIF2 , demonstrating an involvement of viral protein function in inducing this antiviral response. This analysis of eIF2 phosphorylation, coupled with earlier findings that the eIF4F complex is modified earlier during VSV infection, supports a temporal/kinetic model of translation control, where at times soon after infection, changes in the eIF4F complex result in the inhibition of host protein synthesis; at later times, inactivation of the eIF2 complex blocks VSV protein synthesis.
Received for publication, February 1, 2005
* This work was supported by Public Service Health Service Grants AI052304 and AI32983 from the National Institute of Allergy and Infectious Diseases, NIH (to D.S.L). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by Signal Transduction Mechanisms and Cell Function training program grant CA09422 from NCI and Public Health Service Grant AI051805 from the National Institute of Allergy and Infectious Diseases, NIH. To whom correspondence should be addressed: Tel.: 336-716-2270; Fax: 336-716-9928; E-mail: jconnor{at}wfubmc.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Habjan, A. Pichlmair, R. M. Elliott, A. K. Overby, T. Glatter, M. Gstaiger, G. Superti-Furga, H. Unger, and F. Weber
NSs Protein of Rift Valley Fever Virus Induces the Specific Degradation of the Double-Stranded RNA-Dependent Protein Kinase
J. Virol.,
May 1, 2009;
83(9):
4365 - 4375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Pettit Kneller, J. H. Connor, and D. S. Lyles
hnRNPs Relocalize to the Cytoplasm following Infection with Vesicular Stomatitis Virus
J. Virol.,
January 15, 2009;
83(2):
770 - 780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Renukaradhya, M. A. Khan, D. Shaji, and R. R. Brutkiewicz
Vesicular Stomatitis Virus Matrix Protein Impairs CD1d-Mediated Antigen Presentation through Activation of the p38 MAPK Pathway
J. Virol.,
December 15, 2008;
82(24):
12535 - 12542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Igarashi, M. Murase, A. Iizuka, F. Pichierri, M. Martinkova, and T. Shimizu
Elucidation of the Heme Binding Site of Heme-regulated Eukaryotic Initiation Factor 2{alpha} Kinase and the Role of the Regulatory Motif in Heme Sensing by Spectroscopic and Catalytic Studies of Mutant Proteins
J. Biol. Chem.,
July 4, 2008;
283(27):
18782 - 18791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. W. Whitlow, J. H. Connor, and D. S. Lyles
New mRNAs Are Preferentially Translated during Vesicular Stomatitis Virus Infection
J. Virol.,
March 1, 2008;
82(5):
2286 - 2294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Randall and S. Goodbourn
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
J. Gen. Virol.,
January 1, 2008;
89(1):
1 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Komarova, E. Real, A. M. Borman, M. Brocard, P. England, N. Tordo, J. W.B. Hershey, K. M. Kean, and Y. Jacob
Rabies virus matrix protein interplay with eIF3, new insights into rabies virus pathogenesis
Nucleic Acids Res.,
March 12, 2007;
35(5):
1522 - 1532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Ostertag, T. M. Hoblitzell-Ostertag, and J. Perrault
Cell-Type-Specific Growth Restriction of Vesicular Stomatitis Virus polR Mutants Is Linked to Defective Viral Polymerase Function
J. Virol.,
January 15, 2007;
81(2):
492 - 502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Ostertag, T. M. Hoblitzell-Ostertag, and J. Perrault
Overproduction of Double-Stranded RNA in Vesicular Stomatitis Virus-Infected Cells Activates a Constitutive Cell-Type-Specific Antiviral Response
J. Virol.,
January 15, 2007;
81(2):
503 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. W. Whitlow, J. H. Connor, and D. S. Lyles
Preferential Translation of Vesicular Stomatitis Virus mRNAs Is Conferred by Transcription from the Viral Genome
J. Virol.,
December 1, 2006;
80(23):
11733 - 11742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Connor, M. O. McKenzie, and D. S. Lyles
Role of residues 121 to 124 of vesicular stomatitis virus matrix protein in virus assembly and virus-host interaction.
J. Virol.,
April 1, 2006;
80(8):
3701 - 3711.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|